Explore

Trendline Trendline
Caris Life Sciences Launches AI-Powered Test for Breast Cancer Recurrence Risk

Caris Life Sciences Launches AI-Powered Test for Breast Cancer Recurrence Risk

Caris Life Sciences Launches AI-Powered Test for Breast Cancer Recurrence Risk
Trendline Trendline
Caris Life Sciences Introduces AI-Powered Test for Breast Cancer Recurrence Risk

Caris Life Sciences Introduces AI-Powered Test for Breast Cancer Recurrence Risk

Caris Life Sciences Introduces AI-Powered Test for Breast Cancer Recurrence Risk
Trendline Trendline
Caris Life Sciences Introduces AI-Powered Test for Breast Cancer Recurrence Risk Assessment

Caris Life Sciences Introduces AI-Powered Test for Breast Cancer Recurrence Risk Assessment

Caris Life Sciences Introduces AI-Powered Test for Breast Cancer Recurrence Risk Assessment
Trendline Trendline
Allarity Therapeutics Advances Stenoparib Toward Phase 3 Development for Ovarian Cancer

Allarity Therapeutics Advances Stenoparib Toward Phase 3 Development for Ovarian Cancer

Allarity Therapeutics Advances Stenoparib Toward Phase 3 Development for Ovarian Cancer
Trendline Trendline
Personalized Medicine Market Projected to Reach USD 1,397.63 Billion by 2035 Due to Genomic Advancements

Personalized Medicine Market Projected to Reach USD 1,397.63 Billion by 2035 Due to Genomic Advancements

Personalized Medicine Market Projected to Reach USD 1,397.63 Billion by 2035 Due to Genomic Advancements
Trendline Trendline
Sensei Biotherapeutics Begins Phase 1b/2 Trial of PIKTOR for Advanced Breast Cancer

Sensei Biotherapeutics Begins Phase 1b/2 Trial of PIKTOR for Advanced Breast Cancer

Sensei Biotherapeutics Begins Phase 1b/2 Trial of PIKTOR for Advanced Breast Cancer
Trendline Trendline
Pharmaceutical Leaders Utilize Protein Biomarkers to Mitigate Drug Development Risks

Pharmaceutical Leaders Utilize Protein Biomarkers to Mitigate Drug Development Risks

Pharmaceutical Leaders Utilize Protein Biomarkers to Mitigate Drug Development Risks
Trendline Trendline
Advancements in AI and Genomics Propel Personalized Medicine Market to USD 1,397.63 Billion by 2035

Advancements in AI and Genomics Propel Personalized Medicine Market to USD 1,397.63 Billion by 2035

Advancements in AI and Genomics Propel Personalized Medicine Market to USD 1,397.63 Billion by 2035
Trendline Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion

Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion

Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion
Trendline Trendline
Allarity Therapeutics Advances Stenoparib Manufacturing for Phase 3 Trials in Ovarian Cancer

Allarity Therapeutics Advances Stenoparib Manufacturing for Phase 3 Trials in Ovarian Cancer

Allarity Therapeutics Advances Stenoparib Manufacturing for Phase 3 Trials in Ovarian Cancer
Trendline Trendline
ADC Therapeutics Reports Q1 2026 Financial Results and Operational Updates

ADC Therapeutics Reports Q1 2026 Financial Results and Operational Updates

ADC Therapeutics Reports Q1 2026 Financial Results and Operational Updates
Trendline Trendline
Erasca Shares Plummet Amid Patient Death and Patent Dispute

Erasca Shares Plummet Amid Patient Death and Patent Dispute

Erasca Shares Plummet Amid Patient Death and Patent Dispute